- Endonovo’s
flagship product, SofPulse, is an easy-to-place, non-invasive device
delivering pulsed electromagnetic frequencies to enhance post-surgical
recovery
- The
company’s agreement with Veterans Healthcare Supply Solutions Inc.
includes distribution of SofPulse to Veterans Administration facilities
and Department of Defense health care facilities
- Treatment
with SofPulse allows patients to better manage post-operative pain without
the adverse side effects of narcotics and anti-inflammatory medications
- Endonovo
holds patents and trademarks for several proprietary technologies and
devices
Endonovo Therapeutics Inc. (OTCQB: ENDV) is a
commercial stage developer of non-invasive medical devices designed to deliver
proprietary, patent protected Electroceutical Therapy for the treatment of
inflammatory conditions, cardiovascular diseases and central nervous system
disorders. As an innovative biotechnology company, Endonovo is harnessing
bioelectricity to restore key electrochemical processes that initiate the
anti-inflammatory and growth factor cascades necessary for healing to occur.
The long-term agreement recently signed with Veterans
Healthcare Supply Solutions Inc. (“VHSS”) to directly distribute SofPulse
devices to Veterans Administration facilities and Department of Defense health
care facilities extends beyond traditional distribution methods, Endonovo CEO
Alan Collier said in a news release (http://ibn.fm/MHvji).
“The team at VHSS have streamlined and improved the sales,
marketing and distribution of medical devices to VA and DoD facilities. VHSS is
a true leader in the space and we are thrilled to have the capacity to support
their mission,” Collier stated in a news release. “This agreement, which
includes direct delivery to all medical facilities, extends beyond traditional
distribution and includes access to their 900 Federal Contract Officers as well
as their distribution center with a state-of-the-art ERP and WMS Systems.”
Endonovo’s flagship product, SofPulse, is an easy-to-place,
non-invasive device delivering pulsed electromagnetic frequencies to enhance
post-surgical recovery, and it can be used as a standalone therapy or
integrated into any treatment protocol. SofPulse uses targeted microcurrents to
transmit gentle pulses to the tissue to help reduce swelling and speed up the
natural recovery process.
“VHSS is excited to partner with Endonovo, as our primary
goal is providing leading edge products and services to eligible federal
government health care constituents,” added Gary Skura, VHSS president and
retired Navy pilot with over 30 years of health care distribution experience.
“Our new partnership with Endonovo will certainly allow us to further continue
our core objectives.”
Endonovo’s Electroceutical Therapy is cleared by the U.S.
Federal Drug Administration (FDA) for the palliative treatment of post-surgical
pain and edema (swelling) and is CE-marked in the European Economic Area (EEA)
for the promotion of wound healing and the palliative treatment of
post-surgical pain and edema. The Centers for Medicare and Medicaid Services
(CMS) also has national coverage determination for the reimbursement of
Electroceutical Therapy for the treatment of chronic wounds.
For more information, visit the company’s website at www.Endonovo.com
NOTE TO INVESTORS: The latest news and updates
relating to ENDV are available in the company’s newsroom at http://ibn.fm/ENDV
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment